CDKN3 and neoplasm: In this study, it suggests that the amplication of MLL frequently co-exists with the deletion of CDKN2A. CDKN2A encode cyclin-dependent kinase inhibitor, which have emerged as an important effecter in aging as well as a potent tumor suppressor.